Haeger & Carlsson is seeking a visionary and action-oriented CEO for Simplexia, a Swedish biotech company developing a groundbreaking vaccine against herpes (HSV-2).
Requirements
- Represent the company externally to investors, partners, and media.
- Funding and capital raising through investor networks and capital markets.
- Strategic leadership and business development for clinical development and market establishment.
- Accountability for budget and financial management.
- Operational responsibility for a small organization with short decision-making paths.
- Leadership and culture development to promote an entrepreneurial culture.